1700008G05Rik Activators
ABIN6293282 Activators are a diverse array of chemical compounds that amplify the operational activity of ABIN6293282 through distinct biochemical mechanisms and signaling pathways. Compounds like Forskolin and Ionomycin enhance ABIN6293282's activity by increasing intracellular levels of cAMP and calcium, respectively. Forskolin indirectly activates ABIN6293282 by stimulating the cAMP-PKA signaling axis, which may lead to the phosphorylation of proteins within ABIN6293282's pathway. ABIN6293282 Activators are a curated set of chemical compounds that indirectly augment the functional activity of ABIN6293282 through modulation of various cellular signaling pathways. Forskolin, by elevating cAMP levels, activates PKA, which in turn may phosphorylate and activate proteins within the ABIN6293282 signaling network, thus enhancing ABIN6293282's activity. Similarly, the calcium ionophores Ionomycin and A23187 raise the intracellular calcium concentration, which can potentiate calcium-dependent signaling mechanisms involving ABIN6293282. Furthermore, PMA's activation of PKC and EGCG's inhibition of adverse kinases provide additional routes for enhancing ABIN6293282 activity by altering phosphorylation states of proteins that interact with or regulate ABIN6293282.
Compounds like LY294002 and Wortmannin, through their inhibition of the PI3K pathway, and U0126 and SB203580, through their effects on the MAPK pathway, can shift cellular signaling dynamics in a way that can elevate ABIN6293282 activity. This is achieved by relieving negative feedback or competitive inhibition that would otherwise suppress ABIN6293282's functional role in the cell. In contrast, Sphingosine-1-phosphate, by engaging with its lipid signaling pathway, and Genistein, by inhibiting tyrosine kinase activity, provide additional layers of regulatory influence that can lead to the enhancement of ABIN6293282. Thapsigargin contributes to this collective mechanism by increasing cytosolic calcium, a crucial second messenger that can further potentiate ABIN6293282's activity through calcium-dependent pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin functions as a calcium ionophore, raising intracellular calcium concentrations. This boost in calcium can activate calcium-dependent signaling cascades that include ABIN6293282, enhancing its activity by influencing proteins that interact with or regulate ABIN6293282 function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as an activator of protein kinase C (PKC), which then modulates various signaling pathways. If ABIN6293282 activity is regulated by PKC or pathways modulated by PKC, this compound would enhance the activity of ABIN6293282 through phosphorylation or other regulatory mechanisms. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain types of kinases. If ABIN6293282 is part of a signaling cascade that is negatively regulated by these kinases, EGCG would enhance ABIN6293282 activity by lifting this inhibition. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a lipid signaling molecule that can activate sphingosine-1-phosphate receptors and downstream signaling cascades. If ABIN6293282 is involved in these pathways, its activity would be enhanced by this lipid mediator. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could lead to the enhancement of ABIN6293282 activity if PI3K negatively regulates pathways involving ABIN6293282, by reducing competitive signaling through the PI3K pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. If ABIN6293282 operates within a pathway regulated by p38 MAPK, then inhibition by SB203580 could enhance ABIN6293282's activity by alleviating suppressive effects mediated by p38 MAPK. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels. Enhanced calcium signaling can indirectly activate ABIN6293282 if it is part of calcium-dependent regulatory processes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. If ABIN6293282 is regulated by a pathway that involves tyrosine kinase activity, the inhibition by Genistein could enhance ABIN6293282 activity by reducing negative regulatory signals. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore like Ionomycin, which increases intracellular calcium levels and can enhance ABIN6293282 activity through similar calcium-dependent signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K. If ABIN6293282 is part of a signaling cascade that is under negative regulation by PI3K, Wortmannin would enhance ABIN6293282 activity by reducing PI3K-mediated inhibitory signals. | ||||||